Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer.
Yagishita S, Horinouchi H, Sunami KS, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T, Ohe Y.
Yagishita S, et al. Among authors: furuta k.
Cancer Sci. 2015 Oct;106(10):1402-7. doi: 10.1111/cas.12740. Epub 2015 Aug 18.
Cancer Sci. 2015.
PMID: 26177347
Free PMC article.